Rebound
Showing 51 - 75 of 926
HIV/AIDS Trial in San Francisco (Treatment Interruption Arm)
Recruiting
- HIV/AIDS
- Treatment Interruption Arm
-
San Francisco, CaliforniaUniversity of California San Francisco
Apr 27, 2022
Insomnia, Dementia, Frontotemporal Dementia Trial (Lemborexant 5 MG)
Not yet recruiting
- Insomnia
- +2 more
- Lemborexant 5 MG
- (no location specified)
Oct 16, 2023
Hyperglycaemic Crisis in Diabetes, Diabetic Ketoacidosis, Hyperglycaemic Hyperosmolar Nonketotic Syndrome Trial in Changhua city
Recruiting
- Hyperglycaemic Crisis in Diabetes Mellitus
- +2 more
- Insulin Glargine 300 UNT/ML [Toujeo]
-
Changhua city, TaiwanChanghua Christian Hospital
Mar 8, 2022
Stomach Diseases Trial in Genève, Sion (Esomeprazole: Nexium® 20mg, Astra Zeneca, CYP2C19 phenotypical analysis, Placebo)
Recruiting
- Stomach Diseases
- Esomeprazole: Nexium® 20mg, Astra Zeneca
- +2 more
-
Genève, Switzerland
- +1 more
Jan 3, 2022
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
Quality of Recovery Trial in Karaman (Placebo-Transcutaneous Electrical Nerve Stimulation (TENS), Transcutaneous Electrical
Recruiting
- Quality of Recovery
- Placebo-Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcutaneous Electrical Nerve Stimulation (TENS)
-
Karaman, TurkeyKaraman Training and Research Hospital
Apr 27, 2023
A Prospective Monitoring Study for Those Individuals Treated
Enrolling by invitation
- COVID-19
-
San Diego, CaliforniaScripps Research Institute
Nov 14, 2022
Osteoporosis, Postmenopausal Trial (Zoledronate, Placebo)
Not yet recruiting
- Osteoporosis, Postmenopausal
- Zoledronate
- Placebo
- (no location specified)
Dec 15, 2022
DKA Trial in Saint Paul (Insulin Glargine)
Recruiting
- DKA
- Insulin Glargine
-
Saint Paul, MinnesotaRegions Hospital
Aug 21, 2023
Alendronate inWeekly Effervescent Tablet Formulation Following
Recruiting
- Postmenopausal Osteoporosis
- Binosto 70Mg Effervescent Tablet
-
Athens, Attiki, Greece251 Hellenic Air Force & VA General Hospital
Nov 6, 2022
HIV Trial in Gent (treatment interruption after in depth sampling under CART)
Completed
- HIV
- treatment interruption after in depth sampling under CART
-
Gent, Oost-Vlaanderen, BelgiumUZ Gent
Sep 29, 2021
Safety of Therapeutic Step-down in Neuromyelitis Optica
Completed
- Neuromyelitis Optica
-
Strasbourg, FranceService de Neurologie - Hôpitaux Universitaires de Strasbourg
Jan 20, 2022
Skin Tumor Malignant, Skin Cancer Trial (Ingeo Biopolymer (PLA), Ecoflex 030)
Unknown status
- Skin Neoplasm Malignant
- Skin Cancer
- Ingeo Biopolymer (PLA)
- Ecoflex 030
- (no location specified)
Feb 24, 2020
CKD Patients Treated With Nirmatrelvir-ritonavir
Recruiting
- COVID-19
- +2 more
-
Shatin, New Territories, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Nov 21, 2022
End Stage Renal Disease on Dialysis, Hemodialysis Complication Trial in Manises (Conventional exercise, Exercise during the last
Recruiting
- End Stage Renal Disease on Dialysis
- Hemodialysis Complication
- Conventional exercise
- Exercise during the last two hours of the hemodialysis session
-
Manises, Valencia, SpainHospital de Manises
Sep 6, 2022
Pain After Nerve Block in Surgical Patients
Active, not recruiting
- Regional Anesthesia Morbidity
- +2 more
- Educational intervention
- (no location specified)
Sep 15, 2023
Congenital Cytomegalovirus Infection Trial (Letermovir)
Not yet recruiting
- Congenital Cytomegalovirus Infection
- (no location specified)
Nov 1, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag Olamine
- (no location specified)
Jul 5, 2023
Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)
Not yet recruiting
- Human Immunodeficiency Virus
- 3BNC117-LS
- +2 more
-
New York, New York
- +2 more
Jul 12, 2022
Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)
Recruiting
- Waldenstrom Macroglobulinemia
- Zanubrutinib, Bendamustine and Rituximab
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jun 13, 2023
Observational PIC Destination Cohort
Not yet recruiting
- HIV-1-infection
- (no location specified)
Aug 14, 2023
HIV Trial run by the National Cancer Institute (NCI) (Acute Treatment Interruption)
Recruiting
- HIV
- Acute Treatment Interruption
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 11, 2023